Whitfield L - Search Results

1

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.

Macugen AMD Study Group, Apte RS, Modi M, Masonson H, Patel M, Whitfield L, Adamis AP. Macugen AMD Study Group, et al. Among authors: whitfield l. Ophthalmology. 2007 Sep;114(9):1702-12. doi: 10.1016/j.ophtha.2007.02.021. Epub 2007 May 23. Ophthalmology. 2007. PMID: 17509689 Clinical Trial.

2

Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration.

Basile AS, Hutmacher M, Nickens D, Nielsen J, Kowalski K, Whitfield L, Masayo O, Nakane M. Basile AS, et al. Among authors: whitfield l. J Clin Pharmacol. 2012 Aug;52(8):1186-99. doi: 10.1177/0091270011412961. Epub 2011 Sep 23. J Clin Pharmacol. 2012. PMID: 21947371 Clinical Trial.

3

Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.

Whitfield LR, Porcari AR, Alvey C, Abel R, Bullen W, Hartman D. Whitfield LR, et al. J Clin Pharmacol. 2011 Mar;51(3):378-88. doi: 10.1177/0091270010366446. Epub 2010 Apr 22. J Clin Pharmacol. 2011. PMID: 20413454 Clinical Trial.

4

Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction.

Stern RH, Gibson DM, Whitfield LR. Stern RH, et al. Among authors: whitfield lr. Eur J Clin Pharmacol. 1998 Feb;53(6):475-8. doi: 10.1007/s002280050409. Eur J Clin Pharmacol. 1998. PMID: 9551707 Clinical Trial.

5

Effect of age and gender on pharmacokinetics of atorvastatin in humans.

Gibson DM, Bron NJ, Richens A, Hounslow NJ, Sedman AJ, Whitfield LR. Gibson DM, et al. Among authors: whitfield lr. J Clin Pharmacol. 1996 Mar;36(3):242-6. doi: 10.1002/j.1552-4604.1996.tb04194.x. J Clin Pharmacol. 1996. PMID: 8690818 Clinical Trial.

6

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

Radulovic LL, Cilla DD, Posvar EL, Sedman AJ, Whitfield LR. Radulovic LL, et al. Among authors: whitfield lr. J Clin Pharmacol. 1995 Oct;35(10):990-4. doi: 10.1002/j.1552-4604.1995.tb04015.x. J Clin Pharmacol. 1995. PMID: 8568017 Clinical Trial.

7

Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.

Lathia C, Fleming GF, Meyer M, Ratain MJ, Whitfield L. Lathia C, et al. Among authors: whitfield l. Cancer Chemother Pharmacol. 2002 Aug;50(2):121-6. doi: 10.1007/s00280-002-0468-9. Epub 2002 Jun 28. Cancer Chemother Pharmacol. 2002. PMID: 12172976 Clinical Trial.

8

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.

Boyd RA, Stern RH, Stewart BH, Wu X, Reyner EL, Zegarac EA, Randinitis EJ, Whitfield L. Boyd RA, et al. Among authors: whitfield l. J Clin Pharmacol. 2000 Jan;40(1):91-8. doi: 10.1177/00912700022008612. J Clin Pharmacol. 2000. PMID: 10631627 Clinical Trial.

9

A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates.

Bullen WW, Andress LD, Chang T, Whitfield LR, Welch ML, Newman RA. Bullen WW, et al. Among authors: whitfield lr. Cancer Chemother Pharmacol. 1992;30(3):193-8. doi: 10.1007/BF00686311. Cancer Chemother Pharmacol. 1992. PMID: 1628368

10

Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin.

Dostal LA, Whitfield LR, Anderson JA. Dostal LA, et al. Among authors: whitfield lr. Fundam Appl Toxicol. 1996 Aug;32(2):285-92. doi: 10.1006/faat.1996.0132. Fundam Appl Toxicol. 1996. PMID: 8921332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results